Melacine, the first therapeutic tumour vaccine for metastatic melanoma

Schering is now marketing Melacine, the first therapeutic tumour vaccine for metastatic melanoma.

Melacine will be useful. The incidence of this lethal form of skin cancer is rising faster than any other cancer.

The vaccine consists of broken melanoma cells...and immune system stimulants that help create antibodies for the cancer cells.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote